Cross Population Estimate
|
Year
|
Value
|
Type
|
|
2024
|
16,194
|
Population
|
|
2023
|
16,453
|
Population
|
|
2022
|
16,594
|
Population
|
|
2021
|
16,671
|
Population
|
|
2020
|
16,801
|
Population
|
|
2019
|
0
|
Population
|
|
2018
|
0
|
Population
|
|
2017
|
0
|
Population
|
|
2016
|
0
|
Population
|
|
2015
|
0
|
Population
|
Cross Total Operating Revenue
|
Year
|
Value
|
Type
|
|
2024
|
13,270,679
|
Amount
|
|
2023
|
13,016,430
|
Amount
|
|
2022
|
11,916,839
|
Amount
|
|
2021
|
12,056,263
|
Amount
|
|
2020
|
11,452,497
|
Amount
|
|
2019
|
12,371,156
|
Amount
|
|
2018
|
12,090,111
|
Amount
|
|
2017
|
12,509,305
|
Amount
|
|
2016
|
11,777,280
|
Amount
|
|
2015
|
12,793,846
|
Amount
|
Cross Total Operating Margin
|
Year
|
Value
|
Type
|
|
2024
|
-7,940,784
|
Amount
|
|
2023
|
-6,459,659
|
Amount
|
|
2022
|
-4,812,930
|
Amount
|
|
2021
|
-3,236,368
|
Amount
|
|
2020
|
-3,943,234
|
Amount
|
|
2019
|
-3,660,537
|
Amount
|
|
2018
|
-3,727,670
|
Amount
|
|
2017
|
-2,904,131
|
Amount
|
|
2016
|
-3,339,803
|
Amount
|
|
2015
|
-1,672,793
|
Amount
|
Cross Net Profit
|
Year
|
Value
|
Type
|
|
2024
|
-842,161
|
Amount
|
|
2023
|
-731,013
|
Amount
|
|
2022
|
435,452
|
Amount
|
|
2021
|
6,250,363
|
Amount
|
|
2020
|
-153,863
|
Amount
|
|
2019
|
-315,053
|
Amount
|
|
2018
|
-299,086
|
Amount
|
|
2017
|
325,449
|
Amount
|
|
2016
|
299,104
|
Amount
|
|
2015
|
466,374
|
Amount
|
Cross Total Patient Discharges
|
Year
|
Value
|
Type
|
|
2024
|
346
|
Discharges
|
|
2023
|
412
|
Discharges
|
|
2022
|
578
|
Discharges
|
|
2021
|
556
|
Discharges
|
|
2020
|
572
|
Discharges
|
|
2019
|
567
|
Discharges
|
|
2018
|
582
|
Discharges
|
|
2017
|
609
|
Discharges
|
|
2016
|
623
|
Discharges
|
|
2015
|
657
|
Discharges
|
Cross Net Fixed Assets
|
Year
|
Value
|
Type
|
|
2024
|
6,035,138
|
Amount
|
|
2023
|
6,346,291
|
Amount
|
|
2022
|
6,641,697
|
Amount
|
|
2021
|
6,585,195
|
Amount
|
|
2020
|
2,951,589
|
Amount
|
|
2019
|
1,982,403
|
Amount
|
|
2018
|
1,977,316
|
Amount
|
|
2017
|
2,116,524
|
Amount
|
|
2016
|
2,135,312
|
Amount
|
|
2015
|
2,205,008
|
Amount
|
Cross Long Term Liabilities
|
Year
|
Value
|
Type
|
|
2024
|
301,998
|
Amount
|
|
2023
|
432,099
|
Amount
|
|
2022
|
241,399
|
Amount
|
|
2021
|
415,213
|
Amount
|
|
2020
|
583,008
|
Amount
|
|
2019
|
0
|
Amount
|
|
2018
|
0
|
Amount
|
|
2017
|
0
|
Amount
|
|
2016
|
0
|
Amount
|
|
2015
|
35,534
|
Amount
|
Cross Total Beds
|
Year
|
Value
|
Type
|
|
2024
|
15
|
Beds
|
|
2023
|
15
|
Beds
|
|
2022
|
15
|
Beds
|
|
2021
|
15
|
Beds
|
|
2020
|
15
|
Beds
|
|
2019
|
15
|
Beds
|
|
2018
|
15
|
Beds
|
|
2017
|
15
|
Beds
|
|
2016
|
15
|
Beds
|
|
2015
|
15
|
Beds
|